Iain Chalmers - Net Worth and Insider Trading

Iain Chalmers Net Worth

The estimated net worth of Iain Chalmers is at least $1,638 dollars as of 2024-11-12. Iain Chalmers is the Director of Cardiol Therapeutics Inc and owns about 600 shares of Cardiol Therapeutics Inc (TSX:CRDL) stock worth over $1,638. Details can be seen in Iain Chalmers's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Iain Chalmers has not made any transactions after 2019-10-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Iain Chalmers

To

Iain Chalmers Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Iain Chalmers owns 1 companies in total, including Cardiol Therapeutics Inc (TSX:CRDL) .

Click here to see the complete history of Iain Chalmers’s form 4 insider trades.

Insider Ownership Summary of Iain Chalmers

Ticker Comapny Transaction Date Type of Owner
TSX:CRDL Cardiol Therapeutics Inc 2019-10-17 Director

Iain Chalmers Latest Holdings Summary

Iain Chalmers currently owns a total of 1 stock. Iain Chalmers owns 600 shares of Cardiol Therapeutics Inc (TSX:CRDL) as of October 17, 2019, with a value of $1,638.

Latest Holdings of Iain Chalmers

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:CRDL Cardiol Therapeutics Inc 2019-10-17 600 2.73 1,638

Holding Weightings of Iain Chalmers


Iain Chalmers Form 4 Trading Tracker

According to the SEC Form 4 filings, Iain Chalmers has made a total of 0 transactions in Cardiol Therapeutics Inc (TSX:CRDL) over the past 5 years. The most-recent trade in Cardiol Therapeutics Inc is the acquisition of 600 shares on October 17, 2019, which cost Iain Chalmers around $1,950.

Insider Trading History of Iain Chalmers

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Iain Chalmers Trading Performance

GuruFocus tracks the stock performance after each of Iain Chalmers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Iain Chalmers is 16.85%. GuruFocus also compares Iain Chalmers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Iain Chalmers within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Iain Chalmers's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Iain Chalmers

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -32.07 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -36.16 LIMIT LIMIT LIMIT LIMIT LIMIT

Iain Chalmers Ownership Network

Ownership Network List of Iain Chalmers

No Data

Ownership Network Relation of Iain Chalmers

Insider Network Chart

Iain Chalmers Owned Company Details

What does Cardiol Therapeutics Inc do?

Who are the key executives at Cardiol Therapeutics Inc?

Iain Chalmers is the Director of Cardiol Therapeutics Inc. Other key executives at Cardiol Therapeutics Inc include Senior Officer Guillermo Torre , Director & Senior Officer David Elsley , and Director & Senior Officer Christopher James Waddick .

Cardiol Therapeutics Inc (TSX:CRDL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cardiol Therapeutics Inc (TSX:CRDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cardiol Therapeutics Inc Insider Transactions

No Available Data

Iain Chalmers Mailing Address

Above is the net worth, insider trading, and ownership report for Iain Chalmers. Currently GuruFocus does not have mailing address information for Iain Chalmers.